Dr. Reddy's Laboratories Ltd (RDY) vs Zoetis Inc. (ZTS)
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
- Zoetis Inc. ZTS 79.20 +0.99%
Dr. Reddy's Laboratories Ltd and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $32.4B against $10.7B — 3.0× the size. Zoetis Inc. trades at the lower P/E: 13.0× against 32.9×. Zoetis Inc. grew revenue faster over the last twelve months: 1.58% against −11.6%. Zoetis Inc. has the higher net margin (27.7% vs 9.81%) and the higher return on invested capital (19.6% vs 5.89%). Only Zoetis Inc. pays a dividend (2.64%). Across the 23 metrics below, Zoetis Inc. leads on 17 and Dr. Reddy's Laboratories Ltd on 6.
Valuation
Profitability
| Metric | RDY | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 50.00% | 71.67% | 53.94% |
| Operating margin | 10.91% | 37.13% | 0.00% |
| Net margin | 9.81% | 27.69% | 0.00% |
| Free cash flow margin | 4.05% | 24.43% | 0.00% |
| Return on equity | 8.21% | 64.91% | (0.40%) |
| Return on assets | 5.55% | 17.84% | (3.32%) |
| Return on invested capital | 5.89% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack